8-K ·Filed May 15, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Monitor for any further C-suite departures or changes in commercial execution plans in upcoming quarters. The termination appears routine, but investors should watch for any signs of broader organizational upheaval.
Final — all horizons settled through T+60d
TNDM ▲ +82.84% at T+60d
NEUTRAL call ✓ call won +82.84% · α vs SPY +78.32% · entry $12.82 → $23.44
T+1d
+5.54%
call +5.54% · α +5.60%
$13.53
settled 5mo ago
T+5d
+16.73%
call +16.73% · α +15.77%
$14.97
settled 4mo ago
T+20d
+30.73%
call +30.73% · α +28.61%
$16.76
settled 4mo ago
T+60d
+82.84%
call +82.84% · α +78.32%
$23.44
settled 7w ago
Price Chart
Loading chart...
Executive Summary
Tandem Diabetes terminated EVP and Chief Commercial Officer Mark Novara without cause, effective May 18, 2026. The company emphasizes that its strategy and 2026 goals remain unchanged, suggesting the departure is isolated rather than a broader restructuring signal.
Key Facts
- Mark Novara, EVP and Chief Commercial Officer, terminated without cause
- Last day of employment is May 18, 2026
- Company states strategy and 2026 goals remain unchanged
Financial Impact
No direct financial impact disclosed
Risk Factors
- Potential disruption to sales or commercial operations
- Further departures or organizational changes
Market Snapshot
Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
59% bullish (29 analysts)
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001438133-26-000052 |
| Document: 0001438133-26-000052-index-headers.html | 0001438133-26-000052 |
| Document: 0001438133-26-000052-index.html | 0001438133-26-000052 |
| Document: 0001438133-26-000052.txt | 0001438133-26-000052 |
3 reports for TNDM
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 11, 2026 16w ago | Institutional Cluster | $15.80 $19.90 | ▲ +25.95% | ▲ +21.55% | $16.50 (+4.43%) |
May 15, 2026 20w ago | 8-K | $12.82 $23.44 | ▲ +82.84% | ▲ +78.32% | $16.50 (+28.71%) |
Apr 7, 2026 25w ago | DEFA14A | $19.35 $15.32 | ▼ −20.83% | ▼ −31.28% | $16.50 (−14.73%) |
Showing 3 of 3
US Market Status
Market Closed — Opens Mon (65h 21m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access